Journal Club Premieres with Therapeutic Pipeline

Episode 88

A discussion with dermatologists Dr. Mark Lebwohl and Dr. Andrew Blauvelt.

Join us for our new Psound Bytes Journal Club series discussing noteworthy publications in psoriatic disease. In this first episode, we discuss three recent trial results for therapeutics in the pipeline with dermatologists Dr. Mark Lebwohl, Professor and Chairman Dept. of Dermatology, Icahn School of Medicine, Mt Sinai Health System in New York, and Dr. Andrew Blauvelt, President, Oregon Medical Research Center in Portland, OR.

Publications:

Roflumilast

TyK2 Inhibitor

Bimekizumab